Effect of Correction of Metabolic Acidosis on Serum Interleukin 10 Levels in Chronic Hemodialysis Patients | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 118, Volume 88, Issue 1, July 2022, Page 3029-3032 PDF (451.84 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2022.244532 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mohamed Sary Gharib; Fawzia Hassan Ahmed Abo Ali; Heba William Adly; Hossam Moustafa Elkady | ||||
| Abstract | ||||
| Background: Metabolic acidosis is a common complication in chronic hemodialysis (HD) patients and can cause loss of lean body mass. Interleukin 10 (IL-10) also is increased in chronic HD patients and has a prognostic value. Objectives: The aim of this study was to evaluate the effect of correction of metabolic acidosis on serum IL-10 levels in chronic hemodialysis patients. Patients and Methods: Forty chronic hemodialysis patients with predialysis bicarbonate levels Results: Bicarbonate levels significantly increased at end of study (22.83±0.71 vs 18.85±1.12 mEq/l, p < 0.001). Serum IL-10 levels significantly decreased after correction of metabolic acidosis (19.91±6.68 vs 25.89±10.64 pg/ml, p < 0.001) and the change of IL-10 was significantly correlated with the change in bicarbonate (r = - 0.436, p = 0.005). Conclusions: Correction of metabolic acidosis in chronic hemodialysis patients was associated with decrease in serum IL-10. | ||||
| Keywords | ||||
| Hemodialysis (HD); Interleukin 10 (IL-10); Metabolic acidosis | ||||
|
Statistics Article View: 183 PDF Download: 276 |
||||
